________________
Dear reader,
It’s time for SharpBrains e-newsletter discussing the latest research and innovations to help promote brain health, opening in this occasion with a large and worrying study tracking the long-term neural impact of commonly prescribed medications.
New brain research:
- First, do no harm? Common anticholinergic meds seen to increase dementia risk
- …which is one of the many reasons why these 10 highlights from the 2019 SharpBrains Virtual Summit are so important to shape a better system and future
- New study reinforces the importance of walking through forests for mental and general health
- AARP: A majority of Americans believe dietary supplements improve brain health, despite the lack of evidence
New brain technology:
- The Ontario Brain Institute (OBI) announces six new ONtrepreneurs working at the frontier of applied neurotech
- Monitoring the body’s electrical signalling to enhance brain health
- Few wearable neurotechnologies have been directly tested by high-quality, peer-reviewed research
New brain thinking:
- Watch all Recordings from the 2019 SharpBrains Virtual Summit
- July 9th in Toronto, Canada: Latest research findings on Neuroplasticity and Neuropsychology
- Kindle Countdown Deal to read over the summer (and apply!) a great book on brain health and neuro-fitness
- People spent $1.9 billion last year on apps to keep their brains sharp as they age — here’s what actually works
Last but not least, here is a fun brain teaser for the weekend. What do you see?
Have a great month of July,
The SharpBrains Team